Missionpharma
Missionpharma, a leading provider of healthcare solutions, is headquartered in Denmark and operates extensively across Africa and Asia. Founded in 2000, the company has established itself within the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical equipment. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including pharmaceuticals, vaccines, and diagnostic tools, all tailored to meet the specific needs of healthcare providers in underserved regions. Their unique approach combines quality assurance with competitive pricing, ensuring that vital healthcare resources are available where they are needed most. Recognised for its significant contributions to global health initiatives, Missionpharma has achieved notable milestones, solidifying its position as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Missionpharma's score of 29 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Missionpharma's reported carbon emissions
In 2023, Missionpharma reported carbon emissions of approximately 273,000 tonnes CO2e, all of which were classified under Scope 1 emissions. For the following year, 2024, emissions increased to about 305,000 tonnes CO2e, again solely from Scope 1. Notably, there were no reported emissions from Scope 2 or Scope 3 categories in either year. Despite the increase in emissions, Missionpharma has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company appears to be in the early stages of addressing its carbon footprint, focusing primarily on measuring its emissions without established goals for reduction. Overall, Missionpharma's current climate commitments and emissions data suggest a need for further development in their sustainability strategy to align with industry standards and expectations for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2023 | 2024 | |
|---|---|---|
| Scope 1 | 273,000 | 000,000 |
| Scope 2 | - | - |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Missionpharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
